Observational Study in CLL Patients Receiving BR

NCT02381899 · clinicaltrials.gov ↗

COMPLETED

Status

83

Enrollment

NETWORK

Sponsor class

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG: Bendamustine and Rituximab

Sponsor

Czech CLL Study Group